Curtiss-Wright Corporation (CW) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Curtiss-Wright Corporation on September 11, 2024. The filing discloses the adoption of a written trading plan under Rule 10b5-1 of the Securities Exchange Act of 1934 to facilitate share repurchases.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, or debt figures. The only financial metric disclosed relates to capital allocation:
- Total Share Repurchase Authorization: $400 million available under current authorizations.
- Trading Plan Amount: $100 million allocated for purchases under the new Rule 10b5-1 plan.
- Remaining Authorization: The Company expects $300 million in authorization to remain after the completion of this specific plan.
Material Changes
The material change reported is the formal implementation of a $100 million share repurchase trading plan effective September 11, 2024. This plan is designed to allow the Company to repurchase shares during periods when it might otherwise be restricted by trading blackout periods or insider trading laws.
Guidance, Outlook, and Risks
Outlook and Plan Details: The trading plan will cease on December 31, 2024. Purchases will be made up to the maximum daily target volume allowable under Rule 10b-18. The Company anticipates entering the 2025 calendar year with $300 million in remaining repurchase authorization.
Risks and Contingencies: The filing includes standard forward-looking statement disclaimers. Risks include changes in stock price and volume, volatility of common stock, adverse developments in the trading of exchange-traded securities, and unexpected capital investment requirements. The Company does not undertake to update forward-looking statements.
Investor Verification Checklist
- Verify the total number of shares repurchased and the average price paid per share in subsequent Form 10-Q filings.
- Confirm the actual remaining balance of the $400 million repurchase authorization after the December 31, 2024, deadline.
- Review the Company's 2023 Form 10-K and Q2 2024 Form 10-Q for comprehensive risk factors and financial performance data not included in this 8-K.